Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Recruiting Phase 2 Trials for Osimertinib (DB09330)

Also known as: Stage IIIB Lung Non-Small Cell Cancer AJCC v7

IndicationStatusPhase
DBCOND0090338 (Stage IIIB Non-Small Cell Lung Cancer AJCC v7)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03191149Osimertinib in Treating Patients With Stage IIIB-IV or Recurrent Non-small Cell Lung Cancer With EGFR Exon 20 Insertion MutationsTreatment